Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01854242 · ClinicalTrials.gov registry record

Study of the Relationship Between Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease

A clinical trial, sponsored by University of Florida.

Completed
Registry status
50
Enrollment target

NCT01854242 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01854242 has completed, sponsored by University of Florida.

COMPLETED
Registry status
50 participants
Enrollment target

Study Summary

The purpose of this research study is to understand the relationship between inflammatory bowel disease (IBD) and Glycogen storage disease (GSD)type Ia. GSD type Ib has been established to have an association with IBD with clinical and histologic features that mirror those of Crohn disease. Development of the disease seems to be related to the defect of neutrophil function in individuals with GSD type Ib and subsequent colonic inflammation. In the last decade, it has become a standard for patients with GSD type Ib and gastrointestinal symptoms to be evaluated for IBD. Patients with GSD type Ia were not recognized to have similar gastrointestinal symptoms until recently. The prevalence of IBD is greater in patients with GSD type Ia versus the general population.

Interventions

  • OTHER Glycogen Storage Disease type Ia patients

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2013-11
Est. Completion 2014-10

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT01854242

The ClinicalTrials.gov registry entry for NCT01854242 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Glycogen Storage Disease type Ia patients is the first listed.

NCT01854242 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01854242 about?

NCT01854242 is a clinical study titled "Study of the Relationship Between Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease". The purpose of this research study is to understand the relationship between inflammatory bowel disease (IBD) and Glycogen storage disease (GSD)type Ia. GSD type Ib has been established to have an association with IBD with clinical and histologic features that mirror those of Crohn disease. Developm...

What is the current status of trial NCT01854242?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2013-11. Estimated completion is 2014-10.

What interventions are being tested in trial NCT01854242?

The interventions under investigation include: Glycogen Storage Disease type Ia patients (OTHER).

Who is sponsoring clinical trial NCT01854242?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.